Target intelligence / Profile preview

Ribosomal 50S subunit (50S subunit)

Target
50S subunit
Molecular classification
Ribosome, Ribonucleoprotein complex, Macromolecular complex, Other
01

Overview

The ribosomal 50S subunit is the larger component of the prokaryotic 70S ribosome (found in bacteria and archaea) and is essential for protein synthesis. It consists of ribosomal RNA (23S and 5S rRNA) and about 31 proteins, forming a complex structure that catalyzes peptide bond formation (peptidyl transferase activity) during the elongation phase of translation. Functionally, the 50S subunit is targeted by several classes of antibiotics, including macrolides, chloramphenicol, and oxazolidinones, many of which inhibit bacterial growth by interfering with protein synthesis. Structural differences between bacterial and archaeal 50S subunits underlie differences in antibiotic sensitivity. The subunit’s integrity and correct assembly are maintained by a coordinated sequence of protein and RNA interactions, with specialized assembly factors ensuring only fully mature subunits participate in translation. The 50S ribosomal subunit is a critical therapeutic target for antibacterial drugs and a molecular biomarker to differentiate bacterial infection[1][3][4][7].

Other names
Prokaryotic large ribosomal subunitlarge ribosomal subunit (prokaryote)50S large subunit50S ribosome subunit
02

Mechanism of action

Inhibition of protein synthesis by binding to 50S and blocking peptide elongation; Inhibition of peptidyl transferase activity, preventing peptide bond formation; Disruption of tRNA translocation or exit site binding; Inhibition of ribosomal assembly

03

Biological functions

Protein synthesis (translation)Peptide bond formationCatalysis of peptidyl transferase activityFacilitation of ribosomal assembly and functionOther
04

Disease associations

Infection (antibiotic target in bacterial infections)Other
05

Safety considerations

Off-target effects on mitochondrial ribosomes (in rare cases)Development of resistance (e.g., methylation, mutation, efflux)Hypersensitivity or allergic reactions to antibioticsPotential disruption of normal microbiota
06

Interacting drugs

Macrolides (e.g., erythromycin, clarithromycin, azithromycin)

5 more in the full profile.

07

Biomarkers

Presence of 50S-specific rRNA or proteins (for bacterial infection identification)Detection of resistance genes or mutations (e.g., methylation of 23S rRNA conferring macrolide resistance)

Beyond the preview

Go deeper on Ribosomal 50S subunit (50S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal 50S subunit (50S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call